PDX Pharmaceuticals
PrivateLast Round
Grant
Sep 23, 2024
Total Funding Raised
$8.22M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
PDX Pharmaceuticals is a biopharmaceutical company that develops next-generation combination immunotherapies for cancer using a novel nanotechnology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PDX Pharmaceuticals Comparables
Compare PDX Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lemonex Inc. | 79% | |
| Thalia Therapeutics PLC | 76% | |
| Sirnaomics | 74% | |
PDX Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 23, 2024 | ||||
| Grant | Jul 6, 2023 | ||||
| Grant | Feb 21, 2023 | ||||
| Series A Extension | Feb 9, 2021 | ||||
| Series A | Jan 16, 2020 | ||||
Grant | May 1, 2017 |
Key People
Founding team and executive leadership
PDX Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| The Wayne D. Kuni & Joan E. Kuni Foundation | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 27, 5.8x the trailing average.
- Jan 20, 2026
Monthly visitors increased 289% MoM, reaching 3.5K.
PDX Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PDX Pharmaceuticals's valuation, stock price, and market status.